These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA, Kligerman J. ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974 [Abstract] [Full Text] [Related]
24. Towards further understanding of prognostic factors for head and neck cancer patients: the example of hypopharyngeal cancer. Hall SF, Groome PA, Irish J, O'Sullivan B. Laryngoscope; 2009 Apr; 119(4):696-702. PubMed ID: 19205009 [Abstract] [Full Text] [Related]
25. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):603-7. PubMed ID: 18559726 [Abstract] [Full Text] [Related]
29. The effect of comorbidity on quality of life during radiotherapy in head and neck cancer. Oozeer NB, Benbow J, Downs C, Kelly C, Welch A, Paleri V. Otolaryngol Head Neck Surg; 2008 Aug; 139(2):268-72. PubMed ID: 18656727 [Abstract] [Full Text] [Related]
30. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ. J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542 [Abstract] [Full Text] [Related]
31. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, Zheng H, Lauwers GY, Ferrone CR. Arch Surg; 2009 May; 144(5):441-7; discussion 447. PubMed ID: 19451486 [Abstract] [Full Text] [Related]
32. Factors that influence treatment decision in older patients with resectable head and neck cancer. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Laryngoscope; 2007 May; 117(5):835-40. PubMed ID: 17473679 [Abstract] [Full Text] [Related]
36. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI. Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741 [Abstract] [Full Text] [Related]
37. A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma. Jaber JJ, Moreira J, Canar WJ, Bier-Laning CM. Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1147-53. PubMed ID: 19917929 [Abstract] [Full Text] [Related]
38. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Moncrieff M, Sandilla J, Clark J, Clifford A, Shannon K, Gao K, O'Brien C. Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611 [Abstract] [Full Text] [Related]
39. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He S. Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278 [Abstract] [Full Text] [Related]